| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |